Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berruti

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
Tumori|December 23, 1998
Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare TumorsS Bretti, A Berruti, L Dogliotti, et al.
Endocrine-Related Cancer|March 25, 2005
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory diseaseA Berruti, A Mosca, M Tucci, et al.
European Review for Medical and Pharmacological Sciences|November 20, 2020
New models of care and multidimensional solutions for oncological patients in the post-acute SARS-COV-2 period: a "Second Phase" also for cancer patientsF Consoli, C Cristini, M G Guarinoni, et al.
Plos One|September 20, 2021
Racial and ethnic disparities in HIV diagnoses among heterosexually active persons in the United States nationally and by state, 2018Erika G Martin, Bahareh Ansari, Rachel Hart-Malloy, et al.
British Journal of Cancer|September 11, 2003
Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancerA Bottini, A Berruti, M P Brizzi, et al.
Journal of Endocrinological Investigation|May 16, 2006
Prevalence of adrenal incidentaloma in a contemporary computerized tomography seriesS Bovio, A Cataldi, G Reimondo, et al.
The Journal of Infectious Diseases|February 22, 2023
The Estimated Lifetime Quality-Adjusted Life-Years Lost Due to Chlamydia, Gonorrhea, and Trichomoniasis in the United States in 2018Yunfei Li, Shiying You, Kyueun Lee, et al.
British Journal of Cancer|January 1, 1997
Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic diseaseM Tampellini, A Berruti, A Gerbino, et al.
European Journal of Endocrinology|April 17, 2019
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrenceA Calabrese, V Basile, S Puglisi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 19, 2007
Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysisA Dovio, D Generali, M Tampellini, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Tumori|December 23, 1998
Combined epirubicin and interleukin-2 regimen in the treatment of malignant mesothelioma: a multicenter phase II study of the Italian Group on Rare TumorsS Bretti, A Berruti, L Dogliotti, et al.
Endocrine-Related Cancer|March 25, 2005
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory diseaseA Berruti, A Mosca, M Tucci, et al.
European Review for Medical and Pharmacological Sciences|November 20, 2020
New models of care and multidimensional solutions for oncological patients in the post-acute SARS-COV-2 period: a "Second Phase" also for cancer patientsF Consoli, C Cristini, M G Guarinoni, et al.
Plos One|September 20, 2021
Racial and ethnic disparities in HIV diagnoses among heterosexually active persons in the United States nationally and by state, 2018Erika G Martin, Bahareh Ansari, Rachel Hart-Malloy, et al.
British Journal of Cancer|September 11, 2003
Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancerA Bottini, A Berruti, M P Brizzi, et al.
Journal of Endocrinological Investigation|May 16, 2006
Prevalence of adrenal incidentaloma in a contemporary computerized tomography seriesS Bovio, A Cataldi, G Reimondo, et al.
The Journal of Infectious Diseases|February 22, 2023
The Estimated Lifetime Quality-Adjusted Life-Years Lost Due to Chlamydia, Gonorrhea, and Trichomoniasis in the United States in 2018Yunfei Li, Shiying You, Kyueun Lee, et al.
British Journal of Cancer|January 1, 1997
Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic diseaseM Tampellini, A Berruti, A Gerbino, et al.
European Journal of Endocrinology|April 17, 2019
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrenceA Calabrese, V Basile, S Puglisi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 19, 2007
Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysisA Dovio, D Generali, M Tampellini, et al.
Pageof 15